Research Grants (5,397)

GRK 2504: LCMV as model for immune intervention by antigen targeting in chronic viral infections (B2) (GRK 2504 B2)

Third Party Funds Group - Sub project (01.01.2019 – 30.09.2028)

Part of GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504)

GRK 2504: Enhancing antiviral immunity by blocking SAMHD1 activity (A3) (GRK 2504 A3)

Third Party Funds Group - Sub project (01.01.2019 – 30.09.2028)

Part of GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504)

GRK 2504: Enhancing immunogenicity of Human T-cell leukaemia virus Type 1 (HTLV-1) by interfering with viral transcription (A2) (GRK 2504 A2)

Third Party Funds Group - Sub project (01.01.2019 – 30.09.2028)

Part of GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504)

GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504)

Third Party Funds Group - Overall project (01.01.2019 – 30.09.2028)

Astrophysics Center for Multimessenger studies in Europe (ACME)

Third Party Funds Group - Sub project (01.09.2024 – 31.08.2028)

Part of Astrophysics Center for Multimessenger studies in Europe

Learning with Music Signals: Technology Meets Education (MU 2686/15-1 (No. 500643750))

Third party funded individual grant (01.09.2023 – 31.08.2028)

Tackling limitations of future relevant thermo-chemical reactions by exploiting the dynamic surface behaviour of complex mixed metal oxides (DynaMMO)

Third party funded individual grant (01.08.2023 – 31.07.2028)

"Das onkologische Versorgungssystem als Zugangsbarriere: Die Perspektiven der Migrantenpatientinnen/Migrantenpatienten und der Behandelnden (MIGRA-CARE)" (MIGRA-CARE (PM UKER))

Third party funded individual grant (01.08.2025 – 31.07.2028)

NSF-DFG MISSION: Elucidating the dynamics of nanocrystal formation and transformation using multimodal in-situ electron microscopy

Third party funded individual grant (01.07.2025 – 30.06.2028)

Targeting the roots of cancer metastasis and therapy resistance (BR 1399/17-1)

Third party funded individual grant (01.07.2023 – 30.06.2028)